US Neurointerventional Devices Market, September 2016

Neurointerventional radiology/surgery, or neurovascular intervention, is a relatively new medical specialty employing minimally invasive endovascular techniques to treat vascular diseases of the brain. Neurointerventional devices, which contributed sales of more than $870m in the US in 2015, involve a variety of standard and application-specific transcatheter tools and techniques for the treatment of cerebrovascular pathologies (such as aneurysms, arteriovenous malformations [AVMs], and acute and chronic thromboembolic and atherosclerotic occlusions) that prompt clinically significant distortions of cerebral blood flow and carry a high risk of catastrophic breakdowns of cerebrovascular circulation manifested by hemorrhagic or ischemic stroke.

The scope of neurointerventional device market analysis offered in this report includes the following medical devices sold in the US:

• endovascular/transcatheter embolization systems for cerebral aneurysms and AVMs
• adjuvant embolic coil-containment stenting for the management of wide-neck aneurysms
• novel specialty stent graft-based flow redirection, or flow-diversion devices for large wide-neck aneurysms
• carotid artery stent (CAS) systems for treatment of high-grade carotid stenosis
• mechanical cerebral thrombectomy systems targeting selected patient subsets with acute ischemic stroke